Introduction {#sec1}
============

Intracardiac masses represent a clinical challenge. The differential diagnosis is extensive, and the gold standard for diagnosis, which is biopsy, is not easily achievable, resulting in an overreliance on noninvasive imaging to establish a diagnosis. We report two patients with left atrial thrombi misdiagnosed on echocardiography as myxomas.

Case Presentation {#sec2}
=================

Patient 1 {#sec2.1}
---------

A 38-year-old woman with a medical history of hyperlipidemia and migraines presented to the emergency department with dyspnea on exertion, chest pain, and syncope. Vital signs were as follows: blood pressure 100/83 mm Hg, heart rate 111 beats/min, respiratory rate 15 breaths/min, body temperature 37.9°C, and oxygen saturation 96% on room air. Physical examination was significant for jugular venous pressure elevation to the angle of the mandible, reduced breath sounds at the mid and lower right hemithorax, and a grade 2/6 diastolic rumbling murmur over the mitral area. Laboratory blood tests were significant for an elevated white blood cell count of 17,000/μL, as well as alanine transaminase of 795 U/L, aspartate transaminase of 794 U/L, and an international normalized ratio of 1.68. Electrocardiography showed sinus tachycardia, left atrial enlargement, and nonspecific T-wave abnormality. Chest radiography revealed airspace opacities in the right mid and lower lobes. The patient was admitted for a presumptive diagnosis of pneumonia, and treatment with intravenous antibiotics ensued. Because of the physical examination findings, transthoracic echocardiography was performed and showed severe rheumatic mitral stenosis, with a mean gradient of 29 mm Hg, severe right ventricular systolic dysfunction, severe left atrial enlargement, and a 24 × 21 mm left atrial mobile mass attached to the interatrial septum with morphologic features consistent with myxoma ([Figure 1](#fig1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}, [Figure 3](#fig3){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}). Intraoperative transesophageal echocardiography confirmed the findings of transthoracic echocardiography ([Figure 5](#fig5){ref-type="fig"}, [Figure 6](#fig6){ref-type="fig"}, [Figure 7](#fig7){ref-type="fig"}, [Video 1](#mmc1){ref-type="supplementary-material"}, [Video 2](#mmc2){ref-type="supplementary-material"}, [Video 3](#mmc3){ref-type="supplementary-material"}). The patient subsequently underwent cardiac surgery for mitral valve replacement and myxoma resection. The gross appearance of the left atrial mass was consistent with a thrombus, which was confirmed by microscopic examination.Figure 1Patient 1: transthoracic echocardiogram, parasternal long-axis view. *Red arrow* points to the left atrial mass. *LA*, Left atrium; *LV*, left ventricle; *RV*, right ventricle.Figure 2Patient 1: transthoracic echocardiogram, parasternal short-axis view. *Red arrow* points to the left atrial mass. *White arrow* points to the tricuspid valve. *AV*, Aortic valve; *LA*, left atrium; *RA*, right atrium; *RV*, right ventricle.Figure 3Patient 1: transthoracic echocardiogram, apical four-chamber view. *White arrow* points to left atrial mass. *Red arrow* points to rheumatic stenosis of the mitral valve. *LV*, Left ventricle; *RA*, right atrium; *RV*, right ventricle.Figure 4Patient 1: transthoracic echocardiogram, apical four-chamber view, continuous-wave spectral Doppler interrogation of the mitral inflow showing high velocities and gradients.Figure 5Patient 1: transesophageal echocardiogram, midesophageal four-chamber view. A 2.4-cm heterogenous mass with a well-defined border is seen in the left atrium.Figure 6Patient 1: transesophageal echocardiogram, midesophageal four-chamber view, zoomed on the left atrial mass and showing echocardiographic heterogeneity.Figure 7Patient 1: transesophageal echocardiogram, midesophageal bicaval view, demonstrating the attachment of the mass to the interatrial septum.

Patient 2 {#sec2.2}
---------

A 69-year-old woman with a medical history of hypertension, hyperlipidemia, hyperthyroidism, and chronic heart failure with preserved ejection fraction presented to the emergency department with dizziness and back pain of 5 days in duration. Her vital signs were as follows: heart rate 147 beats/min, blood pressure 137/76 mm Hg, respiratory rate 18 breaths/min, body temperature 36.7°C, and oxygen saturation 100% on room air. Physical examination showed a well-appearing average-built woman, with head and neck examination results without jugular venous pressure elevation or carotid bruits. Precordial examination revealed rapid irregular cardiac rhythm with no appreciable murmur, and the lungs were clear to auscultation bilaterally. The rest of the physical examination was unremarkable. Laboratory results showed a white blood cell count of 13,000/μL, hemoglobin of 13.6 g/dL, a platelet count of 228,000/μL, serum creatinine of 0.8 mg/dL, and pro--brain natriuretic peptide of 10,969 pg/mL. Electrocardiography showed atrial fibrillation with a rapid ventricular response of 140 beats/min. Chest radiography did not reveal significant abnormalities.

The patient was admitted for a presumptive diagnosis of acute heart failure exacerbation and new-onset rapid atrial fibrillation. She was treated with intravenous diuretics and systemic anticoagulation with unfractionated heparin infusion. Transthoracic echocardiography showed preserved biventricular systolic function, no significant valvular disease, spontaneous left atrial contrast, and a 1.5-cm left atrial mass attached to the interatrial septum. Chest computed tomographic angiography performed as part of the emergency department evaluation also demonstrated the left atrial mass ([Figure 8](#fig8){ref-type="fig"}). Transesophageal echocardiography followed, confirming the presence of 1.4 × 1.5 cm, mobile, polypoid-shaped left atrial mass with a smooth surface and heterogenous appearance as well spontaneous contrast in the left atrial cavity ([Figure 9](#fig9){ref-type="fig"}, [Video 4](#mmc4){ref-type="supplementary-material"}). The attachment site was the anteroinferior portion of the interatrial septum via a narrow base. A stalk could not be clearly visualized ([Figure 10](#fig10){ref-type="fig"}, [Figure 11](#fig11){ref-type="fig"}, [Figure 12](#fig12){ref-type="fig"}, [Figure 13](#fig13){ref-type="fig"}, [Figure 14](#fig14){ref-type="fig"}, [Videos 5](#mmc5){ref-type="supplementary-material"} and [6](#mmc6){ref-type="supplementary-material"}).Figure 8Patient 2: chest computed tomography with intravenous contrast. *Red arrow* points to a left atrial mass attached to the interatrial septum.Figure 9Patient 2: transesophageal echocardiogram, midesophageal four-chamber view. Spontaneous contrast is seen in the left atrial cavity (*red arrow*).Figure 10Patient 2: transesophageal echocardiogram, midesophageal four-chamber view. *Red arrow* points to the left atrial mass with regular contour and echocardiographic heterogeneity.Figure 11Patient 2: transesophageal echocardiogram, midesophageal short-axis view at the aortic valve (AV) level. Left atrial mass is seen attached to the interatrial septum. *LA*, Left atrium; *RA*, right atrium.Figure 12Patient 2: transesophageal echocardiogram, midesophageal short-axis view at the aortic valve level. Left atrial mass is seen attached to the interatrial septum. The mass is heterogenous and has a lucent core characteristic of cardiac myxoma.Figure 13Patient 2: transesophageal echocardiogram, midesophageal short-axis view at the aortic valve (AV) level. Three-dimensional rendering showing the mass and the anatomic orientation in relation to the aortic valve. *Red arrow* points to the left atrial mass.Figure 14Patient 2: transesophageal echocardiogram, midesophageal three-dimensional rendering showing the anatomic orientation of the left atrial mass in relation to the interatrial septum, mitral valve, and tricuspid valve. *Red arrow* points to the mitral valve. *Yellow arrow* points to the tricuspid valve.

Although the two-dimensional echocardiographic features of the mass were classic for myxoma, contrast echocardiographic evaluation was performed using an ultrasound enhancing agent (Definity; Lantheus Medical Imaging, North Billerica, MA) to further discern the nature of the mass and distinguish a vascular tumor from a thrombus. This step was taken because of the recent diagnosis of atrial fibrillation and heavy spontaneous contrast presence in the left atrial cavity. The periphery of the mass showed contrast enhancement, while the core remained dark without significant contrast uptake ([Figures 15](#fig15){ref-type="fig"} and [16](#fig16){ref-type="fig"}, [Video 7](#mmc7){ref-type="supplementary-material"}). We also delivered several brief high--mechanical index (0.9) ultrasound bursts to observe the perfusion of the mass in real time.Figure 15Patient 2: transesophageal echocardiogram, midesophageal four-chamber view. Low--mechanical index imaging following the injection of perflutren lipid microsphere (Definity) ultrasound enhancing agent. *Red arrow* points to the left atrial mass, exhibiting peripheral enhancement and central clearing suggestive of a vascular tumor with necrotic core. *LA*, Left atrium; *LV*, left ventricle; *LVOT*, left ventricular outflow tract; *MV*, mitral valve; *RA*, right atrium; *RV*, right ventricle.Figure 16Patient 2: transesophageal echocardiogram, midesophageal four-chamber view zoomed on the left atrial mass. Low--mechanical index imaging following the injection of perflutren lipid microsphere (Definity) ultrasound enhancing agent. *Red arrow* points to the left atrial mass, exhibiting peripheral enhancement and central clearing suggestive of a vascular tumor with necrotic core. *Ao*, Aorta; *LA*, left atrium; *RA*, right atrium.

A decision was made to undertake surgical removal of the mass. Six days into the hospital admission and 48 hours after transesophageal echocardiography, the patient was taken to the operating room, where screening transesophageal echocardiography under anesthesia failed to visualize the mass. This was confirmed by a cardiologist, prompting cancelation of the planned surgery ([Video 8](#mmc8){ref-type="supplementary-material"}). The patient was thoroughly examined for evidence of embolization and fortunately was found to have intact neurologic functions and normal peripheral pulses. Head, neck, chest, abdominal, and pelvic computed tomographic angiography were obtained immediately and revealed no evidence of vascular occlusions or organ infarctions.[@bib1]^,^[@bib2] This could be only explained by a misdiagnosis of a thrombus, which resolved with anticoagulation, as a myxoma.

Discussion {#sec3}
==========

The differential diagnosis of an intracardiac mass includes thrombus, vegetation, implanted device, tumor, and artifact. Myxoma is the most common primary cardiac tumor, and the diagnosis often relies on morphology and attachment site.[@bib3]^,^[@bib4] It appears, echocardiographically, as a mobile, heterogenous, polypoid or papillary mass with a lucent core and a smooth or villous surface, with most common site of attachment being the left atrial aspect of the interatrial septum.[@bib3]^,^[@bib4] Although often solitary, multiple tumors can occur, especially in association with certain genetic disorders.[@bib5]

Diagnosis of cardiac masses relies heavily on noninvasive imaging, given the inaccessibility to tissue sampling. Of the available cardiac imaging options, echocardiography remains at the forefront. However, and despite the reported high accuracy of echocardiography in diagnosing intracardiac masses,[@bib6], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11] misdiagnoses have been reported.[@bib12], [@bib13], [@bib14]

Cardiac computed tomography and cardiac magnetic resonance imaging are viable options when echocardiographic findings are inconclusive or technically inadequate, but they are not failure proof.[@bib15], [@bib16], [@bib17], [@bib18] Despite the high accuracy of cardiac magnetic resonance in establishing the nature of cardiac masses, on occasion, thrombi confirmed by histology have been misclassified as myxomas.[@bib16]^,^[@bib18]

Contrast echocardiographic perfusion imaging has been proposed as an excellent tool in diagnosing cardiac masses given its ability to differentiate vascular tumors, which exhibit contrast enhancement, from avascular masses such as thrombi. The accuracy is reported to be as high as 100%, but available evidence stems from small studies.[@bib19], [@bib20], [@bib21]

We describe two patients with left atrial thrombi that exhibited typical location and echocardiographic morphology of left atrial myxomas on the basis of the interpretations of experienced echocardiographers.

Atrial thrombi masquerading as myxomas have been reported in the literature, with echocardiography and cardiac magnetic resonance being among the diagnostic modalities used.[@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44], [@bib45] We conducted a PubMed search for reports of left atrial thrombi misdiagnosed as myxomas and found 24 cases, 20 of which had predisposing procoagulant conditions, namely, atrial fibrillation in 11 patients, mitral stenosis in five patients, left ventricular dysfunction in three patients, and systemic lupus erythematosus in one patient. Details were not available for three patients, and one patient had undergone cardiac transplantation.[@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31], [@bib32], [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40], [@bib41], [@bib42], [@bib43], [@bib44], [@bib45]

These cases as well as the ones from our mini case series highlight a limitation to the reliance on location, mobility, echocardiographic morphology, and, on occasion, magnetic resonance tissue characterization of a cardiac mass to differentiate myxomas from thrombi.[@bib16]^,^[@bib18] This limitation is compounded in those with procoagulant states given the much higher likelihood of thrombus formation, raising the false-positive rate to a potentially unacceptable level.

Contrast echocardiography offers promise, and preliminary data suggest very high accuracy,[@bib19], [@bib20], [@bib21] but our second patient\'s case contradicts that notion. The fundamental concept of contrast echocardiography is the ability to differentiate vascular structures via contrast uptake and thus enhancement. Although thrombi should demonstrate complete lack of contrast enhancement as avascular structures, this assumption might be flawed. Angiographic neovascularization at areas of left atrial thrombi has been long described in association with mitral valve disease. In a retrospective study of 507 patients, coronary angiography demonstrated neovascularity of the left atrium in 30 of 76 patients with left atrial thrombi.[@bib46] This phenomenon was also described in another retrospective analysis as well as several case reports.[@bib34]^,^[@bib47], [@bib48], [@bib49], [@bib50] Whether this neovascularization is specific to patients with severe mitral valve disease is unknown but has not been reported in patients without. This potentially explains the peripheral contrast enhancement observed in our second patient.

Accurate differentiation between left atrial thrombi and myxomas in patients with procoagulant predisposition might not be entirely possible without tissue biopsy. An initial approach of systemic anticoagulation and repeat imaging might be considered in this cohort of patients to avoid unnecessary surgery, but the safety of such approach is not yet established.

Conclusion {#sec4}
==========

Pathology remains the gold standard for diagnosing cardiac masses. Although noninvasive imaging modalities such as echocardiography, contrast echocardiography, and cardiac magnetic resonance have excellent accuracy, misdiagnoses still occur, especially in patients with procoagulant conditions. An initial approach of systemic anticoagulation and repeat imaging might be warranted to avoid unnecessary surgery.

Supplementary Data {#appsec1}
==================

Video 1Patient 1: transesophageal echocardiogram, midesophageal bicaval view. A heterogenous 2.4-cm left atrial mass is seen attached to the interatrial septum.Video 2Patient 1: transesophageal echocardiogram, midesophageal four-chamber view. Mitral valve thickening with restricted opening in diastolic due to commissural fusion (hockey sticking).Video 3Patient 1: transesophageal echocardiogram, midesophageal two-chamber view, mitral valve inflow color Doppler imaging demonstrates flow turbulence and restricted opening at the mitral leaflets\' tips.Video 4Patient 2: transesophageal echocardiogram, midesophageal four-chamber view. Spontaneous contrast is seen in the left atrial cavityVideo 5Patient 2: transesophageal echocardiogram, midesophageal short-axis view at the aortic valve level demonstrating the mobile left atrial polypoid mass attached to the interatrial septum.Video 6Patient 2: transesophageal echocardiogram, midesophageal three-dimensional rendering, showing the anatomic orientation of the left atrial mass in relation to the interatrial septum, mitral valve, and tricuspid valve.Video 7Patient 2: transesophageal echocardiogram, midesophageal four-chamber view. Low--mechanical index imaging following the injection of perflutren lipid microsphere (Definity) ultrasound enhancing agent. Left atrial mass is exhibiting peripheral enhancement and central clearing suggestive of a vascular tumor with necrotic core.Video 8Patient 2: intraoperative transesophageal echocardiogram, midesophageal biplane two-dimensional imaging. Left atrial sweep showing resolution of the left atrial mass.
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